The DOI matches its Crossref record.
HIGH DENSITY LIPOPROTEIN CHOLESTEROL AS A PREDICTOR OF CARDIOVASCULAR DISEASE MORTALITY IN MEN AND WOMEN: THE FOLLOW-UP STUDY OF THE LIPID RESEARCH CLINICS PREVALENCE STUDY
Abstract
With data from the Lipid Research Clinics Prevalence Study used as a baseline, an average of 8.4 years of mortality follow-up has been completed for 8,825 male and female participants who were at least 30 years of age at the time of the study. The participants were examined at 10 North American sites during 1972-1976. Univariate findings for high density lipoprotein (HDL) cholesterol in the 7,569 persons initially free of coronary heart disease indicate an inverse relation with cardiovascular disease mortality for men and women. Controlling for age, low density lipoprotein (LDL) cholesterol, triglycerides, body mass index, systolic blood pressure, and smoking, multivariate analysis results indicate inverse relations between HDL cholesterol and cardiovascular disease mortality. In men, the cardiovascular disease mortality rate ratio for HDL cholesterol increments of 10 mg/dl was similar to the cardiovascular disease mortality rate ratio for LDL cholesterol increments of 30 mg/dl. In women, HDL cholesterol is more closely related to cardiovascular disease than is LDL cholesterol. HDL cholesterol is inversely related to both coronary heart disease and other cardiovascular disease mortality in both sexes, though the relation of HDL cholesterol with coronary heart disease mortality in women approached statistical significance only for the combined end point of suspect and definite cases. No relation was observed in either sex group between HDL cholesterol and noncardiovascular disease mortality. This study, only the second large prospective study evaluating the role of HDL cholesterol in women, confirms both the importance and the independence in both men and women of HDL cholesterol in the epidemiology of coronary heart disease and other cardiovascular disease mortality.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In epidemiological studies, HDL-cholesterol levels are inversely related to the risk of CHD (40)”
From Effects of low-carbohydrate diets v. low-fat diets on body weight and cardiovascular risk factors: a meta-analysis of randomised controlled trials (2016) · cites this paper as [40]
Citations
Cited by
Sorted by citations
Items 401–453 of 453
Hoffman, C. J., Lee, C., & Rasche, R. (1993) · American Journal of Health Promotion · doi:10.4278/0890-1171-7.4.260 · Cited by 1
Role of Exercise and Nutrition
Michelle, P.-M., Artacho, C., & Hagey, A. R. (2007) · Elsevier eBooks · doi:10.1016/b978-012369443-0/50060-0 · Cited by 1
Terapia hormonal sustitutiva en la menopausia
Azaña, M. J. M., & Goy, E. I. (1999) · Información terapéutica del Sistema Nacional de Salud · Cited by 1
Bruschi, F., Meschìa, M., Amicarelli, F., et al. (1997) · Medical science symposia series · doi:10.1007/978-94-011-5560-1_20
Serological Biomarkers in Systemic Lupus Erythematosus
Chan, M. T.-L. (2013) · The University of Bath Online Publications Store (The University of Bath)
Vikstedt, R. (2009) · STM:n Hallinnonalan avoin julkaisuarkisto (Julkari)
Is een laag HDL-cholesterol een risicofactor bij een normaal totaalcholesterol?
Smelt, A. H. M. (2006) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-8808-0_1056
Bamji‐Mirza, M. (2011) · Library and Archives Canada (Government of Canada) · doi:10.20381/ruor-4710
The Treatment of Estrogen Deficiency in Women at Risk for Breast Cancer and Survivors of the Disease
Santen, R. J., & Pinkerton, J. V. (2000) · Endocrine updates · doi:10.1007/978-1-4757-6507-6_4
Bannerman, A., Birnie, D. H., Barrington, H., & Isles, C. (1999) · Coronary Health Care · doi:10.1016/s1362-3265(99)80032-7
Lípidos y lipoproteína (a) en menopáusicas tratadas con tibolona
Delgado, O., Guerra, M., Reyna, E., et al. (2010) · Clínica e Investigación en Ginecología y Obstetricia · doi:10.1016/j.gine.2009.02.005
Metabolic effects of hormone replacement preparations
Sattar, N. A., Packard, C. J., & Jaap, A. J. (1996) · BMJ · doi:10.1136/bmj.312.7046.1608
Tejerizo-López, L. C., Tejerizo-García, A., Sánchez-Sánchez, M. M., García-Robles, R. M., Leiva, A., Benavente, J. M., Teijelo, A. I., Corredera, F., & Pérez-Escanilla, J. A. (2001) · Clínica e Investigación en Ginecología y Obstetricia · doi:10.1016/s0210-573x(01)77105-5
Kaplan, A., Kaplan, S., Marcoe, K. F., Sauvage, L. R., & Hammond, W. P. (1997) · Clinical and Applied Thrombosis/Hemostasis · doi:10.1177/107602969700300305
The impact of GnRH agonist and menotropin therapy on lipoprotein metabolism
Goldman, G., Ovadia, J., & Fisch, B. (1996) · Gynecological Endocrinology · doi:10.3109/09513599609027983
Prevention of cardiovascular disease in women
Shedd, O. L., & Limacher, M. C. (2003) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-003-0028-6
Kim, S., Shin, C., Cho, N. H., Koh, I., Ko, J., & Kwack, K. (2014) · Genes & Genomics · doi:10.1007/s13258-014-0216-7
The high- and low-activity forms of human plasma phospholipid transfer protein (PLTP)
Jänis, M. T. (2006) · STM:n Hallinnonalan avoin julkaisuarkisto (Julkari)
Xu, L. (2012) · Scientific Research and Essays · doi:10.5897/sre11.119
de Carvalho, M. N., de Azevedo, G. D., dos Santos, J. E., et al. (2004) · Revista Brasileira Ginecologia e Obstetrícia · doi:10.1590/s0100-72032004000700010
HDL in HIV-1 infection: a quality perspective through paraoxonase-1 activities
Dias, C. L. G. (2013) · Portuguese National Funding Agency for Science, Research and Technology (RCAAP Project by FCT)
Atherogenic Aspects of Tobacco Smoking in a Coastal Population of Andhra Pradesh, India
Bulliyya, G. (2003) · Journal of Human Ecology · doi:10.1080/09709274.2003.11905636
CARDIOLOGÍA DEL ADULTO - TRABAJOS LIBRES
Ballesteros, L. E., Ramírez, L. M., & Forero, P. L. (2016)
Wilken, L. A., Casper, K. B., & Hagmeyer, K. O. (1998) · Journal of Pharmacy Technology · doi:10.1177/875512259801400107
Cardiovascular Disease in Women: An Update
Huang, H. C., Mehta, P. K., & Merz, C. N. B. (2015) · Springer eBooks · doi:10.1007/978-3-319-22357-5_14
Triglycerides are Independently Predictive of the Extent of Coronary Atherosclerosis
Drexel, H., Muntwyler, J., Beran, J., Schmid, H., Gasser, T., & Amann, F. W. (1996) · Medical science symposia series · doi:10.1007/978-94-009-0311-1_24
Momose, Y., & Une, H. (2000) · JOURNAL OF THE JAPANESE ASSOCIATION OF RURAL MEDICINE · doi:10.2185/jjrm.48.695
Thorn, M. D. (1992) · NCSU Libraries Repository (North Carolina State University Libraries)
Additional Lipid Targets to Modulate Atherosclerotic Plaques beyond LDL-C Lowering
Kataoka, Y., Andres, J., Puri, R., Psaltis, P. J., & Nicholls, S. J. (2016) · Journal of the Japanese Coronary Association · doi:10.7793/jcoron.22.034
The Acute Effects of Submaximal Exercise on HDL Subpopulations
Ichikawa, T., & SAKUMA, N. (1992) · The Journal of Japan Atherosclerosis Society · doi:10.5551/jat1973.20.2-3_133
Kumar, P., Choudhary, A. K., & Das, N. (2017) · Egyptian Journal of Medical Human Genetics · doi:10.1016/j.ejmhg.2017.07.001
Barbosa, I., Coutinho, E. M., Athayde, C., et al. (1998)
KASE, N. G. (2003) · Elsevier eBooks · doi:10.1016/b978-012053642-9/50032-6
Keyhan, G., Rosset, J., Wang, J., et al. (2015)
Barter, P. J. (2009) · Elsevier eBooks · doi:10.1016/b978-141605469-6.50036-6
Kao, W.-T., Yen, Y., & Lung, F. (2015)
The impact of different sources of fatty acids on the fetal programming of atherosclerosis
Gates, L. J. (2021) · Nottingham ePrints (University of Nottingham)
Bamigbowu, O. E. (2021) · Journal of Medical Science And clinical Research · doi:10.18535/jmscr/v9i8.10
Rosenfeld, J. A. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511642111.024
Is een laag HDL-cholesterol een risicofactor bij een normaal totaalcholesterol?
Smelt, A. H. M. (2010) · Bohn Stafleu van Loghum eBooks · doi:10.1007/978-90-313-7508-0_5
Relación de triglicéridos y estimación de riesgo cardiovasculares en mujeres posmenopáusicas
Castro, J., Lares, M., Mena, M. G., et al. (2023) · Revista Digital de Postgrado · doi:10.37910/rdp.2023.12.1.e351
Pahlavanzadeh, B., Zayeri, F., Baghfalaki, T., Hadaeg, F., Khalili, D., Hamrah, M. S., Paul, E., Azizi, F., & Abadi, A. (2019) · Galen Medical Journal · doi:10.31661/gmj.v8i.1516
Barbato, G.-M., Previato, L., & Baggio, G. (1997) · Medical science symposia series · doi:10.1007/978-94-011-5560-1_47
Beson, L. R. (1992) · Defense Technical Information Center (DTIC)
Clinical Assessment of Anti-Atherogenic Function of HighDensity Lipoprotein (HDL)
Ma, F. (2018) · theses.fr (ABES) · doi:10.70675/aec01babza8edz47a2zb4d4zc7c3be00b185
Omics of human plasma lipoproteins : role in cardiometabolic diseases
Zakiev, E. (2019) · theses.fr (ABES) · doi:10.70675/d80fee25za2f2z4790z9eb9ze82d5514a198
Ojo, O. A., Nwafor-Ezeh, P. I., Ojo, A. B., Rotimi, D. E., Ogunlakin, A. D., Akanbi, C. A., Adeyemi, P., & Molehin, O. R. (2026) · Kuwait Journal of Science · doi:10.1016/j.kjs.2026.100594
Vivarelli, S., Formica, T., Fiorino, F. S., Pollicino, M., Savasta, S., Oliveri, C., Trifilò, L., Giambò, F., & Fenga, C. (2026) · Frontiers in Public Health · doi:10.3389/fpubh.2026.1860519 · Cited by 2
Metadata
- Authors
- JACOBS, D. R., MEBANE, I. L., BANGDIWALA, S. I., CRIQUI, M. H., TYROLER, H. A., & PROGRAM, F. T. L. R. C.
- Affiliations
- University of Minnesota (US)
- National Institutes of Health (US)
- University of North Carolina at Chapel Hill (US)
- University of California San Diego (US)
- Venue
- American Journal of Epidemiology
- Publisher
- Oxford University Press (OUP)
- Published
- 1990-01-01
- Volume
- 131
- Issue
- 1
- Pages
- 32-47
- ISSN
- 0002-9262 (ISSN-L)
- 1476-6256
- OpenAlex
- W1930168886
- Cited by
- 452
- References
- 0
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 2 · 2023: 3 · 2022: 6 · 2021: 10 · 2020: 5 · 2019: 7 · 2018: 7 · 2017: 6 · 2016: 8 · 2015: 14 · 2014: 9 · 2013: 12 · 2012: 5
- FWCI
- 25.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Epidemiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (n01hv012156-034)
- National Heart, Lung, and Blood Institute (N01-HV32961, N01-HV 12156, N01-HV12169)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Keywords
- HDL cholesterol, cardiovascular mortality, coronary heart disease mortality, LDL cholesterol, sex differences, cardiovascular risk factors, mortality prediction
- MeSH terms
- Adult, Aged, Aged, 80 and over, Cause of Death, Coronary Disease, Female, Follow-Up Studies, Heart Diseases, Humans, Cholesterol, HDL, Male, Middle Aged, Probability, Sex Factors, Cohort Studies, Prevalence, Multivariate Analysis, Proportional Hazards Models
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review